Abstract
An analytical method was developed for the determination of Lutetium in dilute nitric acid medium using high resolution ICP-AES analytical technique. These studies were required for the determination of Lutetium contents in radiopharmaceutical samples. For the patients suffering from cancers, 177Lu DOTA-TATE peptide receptor radionuclide therapy is used. This necessitates the use of 177Lu and obviously the quantification of Lutetium for its efficient application during medical therapy which is used for the preparation of the patients suffering from cancers. Due to short half life of 177Lu of 6.67 days, it is most likely to get added up with Hf, as it is build up on storage, the undesired impurity element. Hence the effect of Hf on the determination of Lu was studied. Subsequently seven actual samples of 177Lu were analysed for Lu contents after taking into account Hf contribution if any
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
